文献速递急性肾损伤

铁螯合作为急性肾损伤预防的潜在治疗策略

Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention.
PubMed 文献 · J Am Soc Nephrol · 2019-09-25

该综述指出,尽管多年研究,尚无干预措施能可靠预防人类急性肾损伤(AKI),而铁在AKI病理生理中的作用已被认识三十余年。过量非生理性不稳定铁对肾脏及多器官有毒性,铁螯合在多种损伤中具保护作用;小型人类研究初步显示铁螯合预防AKI和肾外急性器官损伤的积极结果。综述汇总动物与人类数据,讨论未来临床试验的实践考虑及现有铁螯合剂的关键差异。

要点

  • 铁螯合在多种损伤模型中显示肾脏保护作用,小型人类研究初步结果积极。
  • 未来AKI预防临床试验需考虑理想临床场景、患者人群、螯合剂及给药方案。
  • 现有铁螯合剂在药代动力学、给药途径和不良反应方面存在关键差异。

核心结论

  • 铁螯合是预防AKI的潜在新策略,但需进一步临床试验验证。

研究设计与样本

  • 综述:汇总铁螯合预防AKI的动物模型和人类研究数据。

主要发现

  • 过量非生理性不稳定铁对肾脏及多器官有毒性,铁螯合在广谱损伤中具保护作用。
  • 小型人类研究初步显示铁螯合预防AKI和肾外急性器官损伤的积极结果。

临床怎么用

  • 未来临床试验需选择理想临床场景、患者人群、铁螯合剂及给药方案。
  • 临床选用铁螯合剂时应考虑药代动力学、给药途径和不良反应差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AKI remains a major public health concern. Despite years of investigation, no intervention has been demonstrated to reliably prevent AKI in humans. Thus, development of novel therapeutic targets is urgently needed. An important role of iron in the pathophysiology of AKI has been recognized for over three decades. When present in excess and in nonphysiologic labile forms, iron is toxic to the kidneys and multiple other organs, whereas iron chelation is protective across a broad spectrum of insults. In humans, small studies have investigated iron chelation as a novel therapeutic strategy for prevention of AKI and extrarenal acute organ injury, and have demonstrated encouraging initial results. In this review, we examine the existing data on iron chelation for AKI prevention in both animal models and human studies. We discuss practical considerations for future clinical trials of AKI prevention using iron chelators, including selection of the ideal clinical setting, patient population, iron chelating agent, and dosing regimen. Finally, we compare the key differences among the currently available iron chelators, including pharmacokinetics, routes of administration, and adverse effects.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Sharma S, Leaf DE. Iron Chelation as a Potential Therapeutic Strategy for AKI Prevention. J Am Soc Nephrol. 2019. PMID: 31554656. doi:10.1681/ASN.2019060595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。